ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 2190 for the last semiannual is 396.60 M HKD, and it's 23.35% higher compared to the previous semiannual. The net income of H1 24 is 74.62 M HKD.